Data / Form D filings / Romark Global Pharma, LLC
Romark Global Pharma, LLC: Form D filings
Romark Global Pharma, LLC, a pharmaceuticals company in Guaynabo, PR, filed 3 Form D notices with the SEC between 2016 and 2017. The latest, on March 8, 2017, reports $13.8 million sold of a $50 million offering to 40 investors.
Find out what Romark Global Pharma, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- B5 TABONUCO STREET, SUITE #216, PMT 317, Guaynabo, PR, 00968
- Phone
- (787) 919-7987
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Puerto Rico
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1666694
The full lists. Form D filings in Puerto Rico: 67 rows, $5, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 8, 2017 | Amendment | $50,000,000 | $13,835,000 | $36,165,000 | 40 | Oct 9, 2015 | sec.gov |
| Mar 15, 2016 | Amendment | $50,000,000 | $10,710,000 | $39,290,000 | 26 | Oct 9, 2015 | sec.gov |
| Feb 24, 2016 | New notice | $50,000,000 | $10,710,000 | $39,290,000 | 26 | Oct 9, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Marc S. Ayers | Executive Officer, Director, Promoter | |
| W. Andrew Krusen Jr. | Director | |
| Celine S. Rossignol | Executive Officer | |
| W. Seymour Holt | Director | |
| Wayne S. Burks | Executive Officer | |
| Jean-Francois Rossignol, M.D., Ph.D. | Executive Officer, Director, Promoter |
Other pharmaceuticals companies in Puerto Rico that filed recently
- MBQ PHARMA INC. $991,038 · Aug 14, 2026
Every Form D from the week of Mar 6, 2017 · All recent filings in Puerto Rico · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Romark Global Pharma, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.